GSK's NASH trial HORIZON completes; malaria and myeloma studies stay in viewNov 13Weekly roundup, 5 itemsbelantamab mafodotinGlaxoSmithKlineUpdated
FDA grants accelerated approval to belantamab mafodotin-blmf for multiple myelomaNov 6Regulatory decisionbelantamabbelantamab mafodotin
GSK's Benlysta label updated by FDA; Phase 2a NASH trial posts resultsOct 30Weekly roundup, 10 itemsaletekitugAmgenUpdated
GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerOct 2Weekly roundup, 11 itemscabotegravirganfeboroleUpdated
New Phase Ib myeloma study registered; GSK-linked FTD trial terminated, BRCA study postedSep 24Weekly roundup, 3 itemsAL001Alector, Inc.
GSK-linked trials: six new registrations this week, all not yet recruitingAug 6Weekly roundup, 6 itemsaletekitugbelantamab
Montefiore registers Phase 1 trial pairing Talquetamab with belantamab mafodotin in myelomaJul 22Trial updatebelantamabbelantamab mafodotin
GSK's DREAMM 12 posts results with 36 enrolled; COSTAR Lung stays active, not recruitingJul 1Weekly roundup, 2 itemsbelantamabbelantamab mafodotin